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Abstract The F-box protein Skp2 is important for S phase
entry and binds to Skp1 and the cyclin A-Cdk2 complex. Here
we report the cloning, analysis of genomic organization and
characterization of a novel gene product related to Skp2 named
FBL2. The human FBL2 gene was found to be a highly
interrupted gene of at least 126.6 kb located on chromosome
17 in close proximity to the TRAP220 gene in a head-to-tail
orientation. The predicted protein contains an F-box and six
perfect C-terminal leucine-rich repeats. Similar to Skp2, this
protein interacts with Skp1 and deletion of the F-box inhibits this
association. However, in contrast to Skp2, FBL2 was detected in
non-proliferating hepatocytes and its expression increased in
growth-arrested liver epithelial cells. In addition, FBL2 was
localized primarily in the cytoplasm concentrated around the
nucleus. Overall, our data indicate that although FBL2 shares
strong structural homology with Skp2 as well as having a similar
ability to associate with Skp1, these proteins likely play distinct
roles and target different substrates to the SCF complex.
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1. Introduction
The activity of cyclin-dependent kinases (Cdks), key regu-
lators of cell cycle progression, is determined by the balance
of positive regulatory subunits known as cyclins and negative
factors such as Cdk2 inhibitors. Expression of these proteins is
tightly controlled at the level of transcription, translation and,
¢nally, protein stability. One of the important post-transcrip-
tion mechanism of regulating protein abundance in eukar-
yotes is a ubiquitin-dependent proteolytic pathway.
Genetic analyses in yeast have identi¢ed a group of genes
involved in the ubiquitin-dependent proteolysis of cell cycle
control proteins such as cyclin-dependent kinase inhibitors
Sic1 and Far1 as well as G1 cyclins Cln1 and Cln2 (reviewed
in [1^3]). Biochemical studies reveal that products of these
genes form a multi-protein complex in yeast cells, the invar-
iable core consisting of Cdc34, Cdc53 and Skp1. In addition,
the last subunit can interact with several proteins character-
ized by the presence of a relatively conserved structural motif
called F-box which is responsible for binding to Skp1 [4]. The
resulting complex, called SCF for Skp1/Cdc53-cullin/F-box
protein, acts as an E3 ubiquitin ligase that allowed the ubiq-
uitination and subsequent proteolysis of Sic1 and Cln1,-2 by
F-box proteins Cdc4 and Grr1 respectively in conjunction
with E2 ubiquitin-conjugation enzyme Cdc34 and E1 ubiqui-
tin-activation enzyme. Thus, F-box containing proteins, by
virtue of their interaction with di¡erent target proteins and
recruiting them for degradation, confer speci¢city to SCF
complexes.
Recent data indicate that the SCF pathway is evolutionarily
conserved since all the subunits of yeast SCF complex have
orthologues in mammals. Human cullin 1 protein, a member
of the Cdc53 family, selectively interacts with human Skp1 [5^
8]. Only a limited number of mammalian proteins containing
an F-box motif have been identi¢ed so far including cyclin F,
Skp2, L-TrCP and NFB42 [9^12]. These proteins were shown
to be associated with Skp1 thus forming speci¢c SCF com-
plexes [4,5,10^17]. The best studied SCFSkp2 complex includes
the invariant core consisting of p19Skp1 and cullin 1 associated
with ubiquitin-conjugating enzyme Cdc34. The F-box compo-
nent of the complex, p45Skp2, binds to Skp1 via an F-box
motif and due to the presence of C-terminal leucine-rich re-
peat (LRR) domain, it interacts with cyclin A-Cdk2 although
some N-terminal sequences appeared also to be involved in
this binding [5,13]. The abundance of Skp2 transcripts and
protein and, consequently, Skp2-cyclin A-Cdk2 complex for-
mation is greatly increased in many transformed cells and
during S phase progression. In addition, inhibition of Skp2
expression prevented entry into S phase in both normal and
transformed cells suggesting that this protein is an important
component of the cell cycle control machinery [8,10].
We report here the identi¢cation of a structural homologue
of Skp2, a protein containing an F-box motif and C-terminal
LRRs. This protein, designated FBL2, interacts with Skp1
through its F-box domain. However, striking di¡erences in
expression and intracellular localization with reference to
Skp2 argue for its distinct role.
2. Materials and methods
2.1. cDNA cloning and plasmid construction
The GenBank database of expressed sequence tags (ESTs) was
searched for sequences related to the F-box region of Skp2 with the
TBLASTN program [18]. ESTs matching to the F-box motif were
retrieved and used to search overlapping ESTs. Obtained contigs of
nucleotide sequences were then translated and analyzed for the pres-
ence of LRRs. One consensus sequence derived from overlapping rat
ESTs encoding very likely a full-length protein was chosen for further
analysis. The cDNA was obtained by polymerase chain reaction
(PCR) ampli¢cation of reverse-transcribed rat hepatoma HTC cell
RNA using the Advantage Polymerase mix (Clontech, Palo Alto,
CA, USA) and the following primers: a sense primer (5P-CATGAG-
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GAGGGACGTGAACGGAGTG-3P) and an antisense primer (5P-
CCTAAGCCGAGGGCAGTTCTGAC-3P). The partial rat Skp2
cDNA encoding the C-terminal part of protein, including F-box
and leucine-rich repeats, and the full-length rat Skp1 coding sequence
were ampli¢ed by PCR from reverse-transcribed rat hepatoma HTC
and rat liver epithelial cell SDVI RNAs respectively using the follow-
ing primers: 5P-CTTCCGGATGAGCTGCTCTTGGGAA-3P and 5P-
TAGACAACTGGGCTTTTGCAGAGTC-3P for Skp2 and 5P-ATG-
CCTACGATAAAGTTGCAGAGT-3P and 5P-TCACTTGTCTTCA-
CACCACTGGTT-3P for Skp1. PCR products were cloned in pCRII
vector (In Vitrogen, NV Leek, The Netherlands) and DNA sequenc-
ing was performed on both strands.
To generate an expression vector encoding the FLB2-GFP fusion
protein, a BamHI-XhoI fragment was released from pCRII-FBL2 and
in-frame subcloned in the same sites of pEGFP-C2 (Clontech). The
expression vectors encoding V5/6UHis-tagged full-length FBL2 and
N-terminal truncation mutants were constructed by PCR ampli¢ca-
tion of the corresponding region and cloning in the pcDNA3.1/V5-His
vector (In Vitrogen). The identical Kozak consensus sequence CAC-
CATG was incorporated at the 5P ends of sense primers to ensure the
equal translation of cloned fragments. All constructs were veri¢ed by
DNA sequencing.
2.2. Determination of exon/intron organization and analysis of
upstream regulatory sequences
The human genomic clone hCIT.131_K_1 (GenBank accession
number AC005288) was used to elucidate the genomic organization
of FBL2 by sequence comparison with FBL2 cDNA. The presence of
splice donor and acceptor sites immediately £anking the alignment
matches helped to predict the positions of exons. Based on the loca-
tion of exon 1, the 2.7 kb upstream genomic sequence was searched
for transcription factor binding sites by MatInspector [19].
2.3. Cell culture and transfections
Hepatocytes from adult male Sprague-Dawley rats were isolated by
a two-step collagenase perfusion procedure. Hepatocytes were seeded
in a mixture of 75% minimum essential medium and 25% medium
199, supplemented with 10% fetal calf serum (FCS) and, per ml:
100 IU penicillin, 100 mg streptomycin sulfate, 1 mg bovine serum
albumin and 5 mg bovine insulin. After cell attachment (4 h later), the
medium was renewed with the same medium deprived of FCS and
supplemented with 1.4U1036 M hydrocortisone hemisuccinate. Faza
967 and FAO, well-di¡erentiated rat hepatoma cell lines derived from
H4IIEC3, and poorly di¡erentiated rat liver hepatoma cells HTC were
grown in a mixture of 50% Ham’s F-12 and 50% NCTC 135 and
Dulbecco’s modi¢ed Eagle’s medium (DMEM), respectively, supple-
mented with 10% FCS. Rat liver epithelial cell lines SDVI and BRL
3A were maintained in Williams’ E medium with 10% FCS. Human
osteosarcoma cells U-2OS were grown in DMEM containing 10%
FCS. U-2OS cells were transiently transfected using liposome-based
transfection reagent DOTAP (Boehringer Mannheim).
2.4. RNA isolation and Northern blot analysis
Total RNA was extracted from adult rat tissue or cultured cells by
the guanidinium thiocyanate procedure. Unless stated otherwise the
cells were harvested at 60^70% con£uence. 20 Wg RNA was separated
by electrophoresis through a 1.2% agarose gel in 2.2 M formaldehyde,
20 mM MOPS (pH 7.0), 10 mM sodium acetate, 1 mM EDTA and
transferred onto a nylon membrane (Hybond N, Amersham) by
capillary blotting. Hybridization was carried out in the presence of
32P-labelled cDNA probe as previously described [20]. The equiva-
lence of RNA loading was assessed by ethidium bromide staining.
2.5. Protein binding assay
[35S]Methionine-labelled full-length FBL2, the deletion mutants and
Skp1 were produced in vitro using the TNT T7 Coupled Reticulocyte
Lysate System (Promega, Carbonnieres, France) according to the
manufacturer’s instructions. 5 Wl FBL2 and its deletion mutant trans-
lation products were mixed with 7.5 Wl Skp1 programmed lysates and
diluted to 150 Wl with binding bu¡er (20 mM Tris-HCl (pH 7.5), 150
mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM EDTA, 1 mM dithio-
threitol and 5 Wg/ml aprotinin, leupeptin, and soybean trypsin inhib-
itor). The mixture was incubated on ice for 30 min and was immu-
noprecipitated with 1 Wg Penta-His antibody speci¢c for 6UHis tag
(Qiagen, Courtaboeuf, France) or anti-V5 antibody (In Vitrogen) for
1 h at 4‡C followed by incubation with protein G-agarose beads
(Pierce, Rockford, IL, USA) for another 1 h. Beads were washed three
times with binding bu¡er, then separated on a 15% SDS-polyacryl-
amide gel, ¢xed, dried and subjected to autoradiography.
3. Results
By using the sequence information derived from ESTs, the
cDNA encoding a 276 amino acid F-box protein was isolated
from rat hepatoma cells HTC (Fig. 1A). Analysis of the de-
duced amino acid sequence showed in addition to the F-box
motif located at the N-terminal region, the presence of six
perfect 26 amino acid LRRs in the C-terminal half of the
protein (Fig. 1B). Thus, together with Skp2, this protein rep-
resents the second member of the subfamily of mammalian F-
box proteins containing LRRs. Therefore it was named FBL2
for F-Box/Leucine-rich repeat protein 2. The GenBank search
revealed the presence of the gene for human FBL2 on the
137 496 bp clone hCIT.131_K_1 from human chromosome
17. The corresponding cDNA was obtained by PCR from
reverse-transcribed human hepatoma Hep3B RNA and com-
parative analysis of amino acid sequence showed very high
homology with the rat counterpart (more than 99% identity).
Comparison of the human FBL2 cDNA sequence to that of
clone hCIT.131_K_1 allowed us to determine the exon/intron
organization of the FBL2 gene (Table 1). Collectively, the
data demonstrate that the FBL2 gene, covering almost the
totality of the clone, is a large (at least 126.6 kb), highly
interrupted gene composed of 10 small exons, most of them
Fig. 1. Amino acid sequence of FBL2 and comparison with Skp2.
A: Deduced amino acid sequence of rat FBL2. The F-box motif is
indicated by a box. B: Alignment of leucine-rich repeat domains at
the C-terminal region of FBL2. C: Sequence alignment of F-box
motif and leucine-rich repeat domains of rat FBL2 and Skp2.
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not exceeding 100 bp. The size of introns ranges from 1.3 to
58.1 kb. Analysis of splice donor/acceptor site sequences re-
vealed that all intron/exon junctions followed the normal con-
sensus sequence rules [21]. Most of the introns (¢ve of nine)
are type 0 introns, which interrupt the code between codons,
and the remaining four introns are type 2 introns (codon
interruption after the second nucleotide). Additionally, we
found that the left extremity of the hCIT.131_K_1 clone con-
tains the 3P end of the thyroid hormone receptor-associated
protein complex component TRAP220 gene, known also as
thyroid hormone receptor interactor 2 (TRIP2), and peroxi-
some proliferator-activated receptor Q-binding protein (PBP)
Table 1
Exon-intron organization of FBL2
Fig. 2. FBL2 associates with Skp1 in vitro. 5 Wl [35S]methionine-la-
belled V5/6UHis-tagged FBL2, deletion mutants FBL2(v1^14) and
FBL2(v1^69) produced in rabbit reticulocyte lysates were mixed
with 7.5 Wl Skp1 programmed lysates in 150 Wl binding bu¡er and
immunoprecipitated with 1 Wg anti-6UHis antibody followed by in-
cubation with protein G-agarose beads. Beads were washed three
times with binding bu¡er and separated on a 15% SDS-polyacryl-
amide gel.
Fig. 3. Expression of FBL2 transcripts in adult rat tissues and in
liver-derived cell lines. A: Total RNA was extracted from adult tis-
sues indicated and subjected to Northern blot analysis using rat
FBL2 cDNA probe. The equivalence of RNA loading was assessed
by hybridization with a housekeeping gene ubiquitin cDNA probe.
B: Total RNA was extracted from primary rat hepatocytes at 4 h
(1) and 48 h of culture (2), from rat hepatoma cells HTC (3), Faza
967 (4) and FAO (5), from rat liver epithelial cells SDVI in the pro-
liferative state (6) and maintained at con£uence for 5 days (7), from
the transformed variant of SDVI in the proliferative state (8) and at
con£uence (9) and from BRL 3A line (10) and analyzed by blot hy-
bridization with rat FBL2 and Skp2 cDNA probes.
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[22,23]. The 2.7 kb portion of the hCIT.131_K_1 clone sepa-
rating the 3P end of TRIP2 from the 5P end of FBL2 was
analyzed for the presence of promoter elements and transcrip-
tion factor binding sites. By MatInspector search we detected
a CCAAT box, two E-boxes and putative binding sites for
Egr-1, Sp1, C/EBP and E2F transcription regulators.
Amino acid sequence similarity search of predicted protein
FBL2 revealed a high homology with two Caenorhabditis el-
egans hypothetical F-box proteins C02F5.7 and C30A5.1
(GenBank accession numbers P34284 and AAB59171, respec-
tively). As expected, signi¢cant homology was found with the
C-terminal half of rat Skp2 encompassing the F-box and
LRRs (Fig. 1C).
The presence of the F-box in FBL2 led us to investigate
whether this protein could bind Skp1 as was shown previously
for Skp2. [35S]Methionine-labelled V5/6UHis-tagged FBL2,
deletion mutants FBL2(v1^14), FBL2(v1^69) and full-length
Skp1 were mixed and immunoprecipitated with anti-6UHis
antibody. Both FBL2 and FBL2(v1^14) interact with Skp1,
whereas FBL2(v1^69) lacking the F-box region failed to bind
this protein (Fig. 2). Similar results were obtained with anti-
V5 antibody (data not shown).
To gain insight into the possible role of FBL2, we per-
formed a comparative analysis of its expression pattern and
intracellular localization with that of Skp2. Total RNA was
extracted from various adult rat tissues and analyzed by hy-
bridization using full-length FBL2 cDNA as a probe. FBL2
mRNA appeared to be expressed ubiquitously, although its
amount varied considerably among the tissues tested. At least
three mRNA transcripts were detected in analyzed tissues
with low sized species enriched in spleen, thymus and testis
and high molecular weight transcripts were predominantly
present in skeletal muscle, heart and brain. The liver expressed
the lowest amounts of transcripts (Fig. 3A). Furthermore,
expression of FBL2 was analyzed in a set of liver-derived cells,
including primary hepatocytes and established cell lines with
di¡erent degrees of tumorigenicity and di¡erentiation. The
gene was expressed in freshly isolated hepatocytes and in-
creased with time in culture in the absence of mitogen stim-
ulation. FBL2 mRNAs were detected in all liver-derived cell
lines analyzed; however, well-di¡erentiated hepatoma cells
FAO and Faza 967 contained higher amounts of transcripts
in comparison to dedi¡erentiated HTC cells. In addition, ex-
pression of FBL2 was related to proliferation status of the
cells. In both normal and transformed rat liver epithelial cells
the amount of mRNA increased in growth-arrested con£uent
cells. In contrast, Northern blot analysis of Skp2 expression
revealed a completely opposite pattern: Skp2 transcripts were
undetectable in non-proliferating primary hepatocytes, abun-
dant in proliferating hepatoma and rat liver epithelial cells
and down-regulated at con£uence (Fig. 3B).
To examine the intracellular localization of FBL2, it was
expressed as a GFP fusion protein in U2-OS cells. The vector
pEGFP-C2 encoding enhanced GFP was used as a control.
Analysis of transfected cells by £uorescence microscopy re-
vealed that in contrast to EGFP, which showed a homogene-
ous intracellular pattern of £uorescence, the £uorescent sig-
nals in cells transfected with the FBL2-GFP construct were
detected in punctuate foci in the cytosol concentrated mainly
around the nuclei (Fig. 4).
4. Discussion
Originally identi¢ed as a protein associated with complexes
of the cell cycle regulators cyclin A and Cdk2, Skp2 was
found to be a component of SCF-type E3 ligases which func-
tion in the ubiquitin-dependent destruction of target proteins.
Due to the presence of the F-box domain Skp2 recruits sub-
strates to the invariable core of E3 ligases which include Skp1
and Cul-1. To identify new Skp2-like proteins we performed a
computational similarity search against EST databases for
cDNA encoding proteins containing the F-box motif and leu-
cine-rich repeats. Using this strategy, we discovered and
cloned an additional member of F-box family, a 276 amino
acid protein which contains six LRRs, and determined the
exon/intron organization of the human FBL2 gene located
on chromosome 17.
To investigate whether FBL2 could form an SCF complex,
we tested its ability to interact with Skp1. We provided evi-
dence that the full-length FBL2 protein and an N-terminal 14
amino acid deletion mutant interact with Skp1, while the F-
box deletion mutant was defective for Skp1 binding. Thus our
data again support the conclusion that the F-box motif is
indispensable for association with Skp1 and that FBL2 also
uses this motif to form an SCFFBL2 complex.
One might expect, based on the presence of similar func-
Fig. 4. Intracellular localization of FBL2. U-2OS cells were transiently transfected with expression plasmids encoding GFP (left panel) or
FBL2-GFP fusion protein (right panel). 18 h after transfection the cells were ¢xed with PBS/4% paraformaldehyde and examined by £uores-
cence microscopy.
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tional domains, F-box and LRRs, in both Skp2 and FBL2,
that these two proteins could have at least related functions.
However, the FBL2 expression pattern was found to be di¡er-
ent from and even opposite to that of Skp2. Indeed, it was
demonstrated that expression of Skp2 is increased in trans-
formed cells and during S phase of the cell cycle [5,8,10]. Skp2
was also induced in regenerating rat liver in vivo and growth
factor-stimulated normal hepatocytes in vitro [24]. Consistent
with previous reports we found that Skp2 was strongly ex-
pressed in proliferating liver-derived cell lines and down-regu-
lated in quiescent cells. In contrast, FBL2 transcripts were
preferably expressed in con£uent growth-arrested cells. In ad-
dition, the nuclear localization of Skp2 [5] was clearly di¡er-
ent from that of FBL2, which was detected in the cytosol
around nuclei.
Taken together our data suggest that despite the large struc-
tural homology with Skp2 and similar capacity to bind Skp1,
FBL2 likely plays a distinct role as argued by the pattern of
its expression in liver-derived cells and intracellular localiza-
tion, the latter probably re£ecting an association with di¡er-
ent target proteins. Indeed, since the binding partners of Skp2,
cyclin A and cdk2, are predominantly nuclear during S phase
this could explain the nuclear co-localization of the associated
SCFSkp2 complex. In contrast, it seems that yet unidenti¢ed
protein(s) binding to SCFFBL2 could target FBL2 to the peri-
nuclear compartment. In line with this possibility we failed to
demonstrate binding of FBL2 to cyclin A-Cdk2 from regen-
erating rat liver using the same assay conditions that have
previously allowed us to detect the association of Skp2 with
this complex (unpublished data).
To date, besides FBL2, ¢ve F-box subunits of SCF complex
have been identi¢ed in mammals: cyclin F, Skp2, highly ho-
mologous L-TrCP1 and L-TrCP2 (KIAA 0696) and NFB42.
In addition to the F-box motif, these proteins contain di¡er-
ent C-terminal domains, known to be involved in protein-
protein interactions. Namely, cyclin F includes a cyclin box
[9], L-TrCP1 and L-TrCP2 contain WD40 repeats [11,14,25],
the C-terminal half of NFB42 shares homology with C. ele-
gans hypothetical protein C14B1.3 [12] and, ¢nally, Skp2 and
FBL2 contain LRRs. Due to the presence of an F-box all
these proteins are able to associate with Skp1, thus forming
the core of the E3 ubiquitin ligase protein complexes which
could recruit speci¢c substrates for degradation. Up to now,
this role was clearly established for L-TrCP only, which is
involved in ubiquitin-dependent proteolysis of L-catenin and
IUBK [14^17,25,26]. The presence of an F-box in FBL2, which
is indispensable for binding of Skp1, strongly suggests that
this protein could interact with and recruit protein(s) for ubiq-
uitination. Studies are in progress to identify proteins that
associate with FBL2 and to de¢ne its role in the ubiquitin-
proteasome pathway.
References
[1] Pagano, M. (1997) FASEB J. 11, 1065^1075.
[2] Elledge, S.J. and Harper, J.W. (1998) Biochim. Biophys. Acta
1377, M61^M70.
[3] Patton, E.E., Willems, A.R. and Tyers, M. (1998) Trends Genet.
14, 236^243.
[4] Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J.W.
and Elledge, S.J. (1996) Cell 86, 263^274.
[5] Lisztwan, J., Marti, A., Sutterlu«ty, H., Gstaiger, M., Wirbelauer,
C. and Krek, W. (1998) EMBO J. 17, 368^383.
[6] Lyapina, S.A., Correll, C.C., Kipreos, E.T. and Deshaies, R.J.
(1998) Proc. Natl. Acad. Sci. USA 95, 7451^7456.
[7] Michel, J.J. and Xiong, Y. (1998) Cell Growth Di¡er. 9, 435^449.
[8] Yu, Z.-K., Gervais, J.L.M. and Zhang, H. (1998) Proc. Natl.
Acad. Sci. USA 95, 11324^11329.
[9] Bai, C., Richman, R. and Elledge, S.J. (1994) EMBO J. 13, 6087^
6098.
[10] Zhang, H., Kobayashi, R., Galaktionov, K. and Beach, D. (1995)
Cell 82, 915^925.
[11] Margottin, F., Bour, S.P., Durand, H., Selig, L., Benichou, S.,
Richard, V., Thomas, D., Strebel, K. and Benarous, R. (1998)
Mol. Cell 1, 565^574.
[12] Erhardt, J.A., Hyniska, W., DiBenedetto, A., Shen, N., Stone,
N., Paulson, H. and Pittman, R.N. (1998) J. Biol. Chem. 273,
35222^35227.
[13] Yam, C.H., Ng, R.W.M., Siu, W.Y., Lau, A.W.S. and Poon,
R.Y.C. (1999) Mol. Cell. Biol. 19, 635^645.
[14] Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M.,
Matsumoto, M., Hattori, K., Higashi, H., Nakano, H., Oku-
mura, K., Onoe¤, K., Good, R.A. and Nakayama, K.-i. (1999)
Proc. Natl. Acad. Sci. USA 96, 3859^3863.
[15] Latres, E., Chiaur, D.S. and Pagano, M. (1999) Oncogene 18,
849^854.
[16] Spencer, E., Jiang, J. and Chen, Z.J. (1999) Genes Dev. 13, 284^
294.
[17] Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge,
S.J. and Harper, J.W. (1999) Genes Dev. 13, 270^283.
[18] Altschul, S.F., Madden, T.L., Scha«¡er, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Nucleic Acids Res. 25,
3389^3402.
[19] Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T.
(1995) Nucleic Acids Res. 23, 4878^4884.
[20] Ilyin, G.P., Langoue«t, S., Rissel, M., Delcros, J.-G., Guillouzo,
A. and Guguen-Guillouzo, C. (1998) Hepatology 27, 1687^1694.
[21] Mount, S.M. (1982) Nucleic Acids Res. 10, 459^472.
[22] Zhu, Y., Qi, C., Jain, S., Rao, M.S. and Reddy, J.K. (1997)
J. Biol. Chem. 272, 25500^25506.
[23] Yuan, C.X., Ito, M., Fondell, J.D., fu, Z.Y. and Roeder, R.G.
(1998) Proc. Natl. Acad. Sci. USA 95, 7939^7944.
[24] Bilodeau, M., Talarmin, H., Ilyin, G., Rescan, C., Glaise, D.,
Cariou, S., Loyer, P. and Guguen-Guillouzo, C. (1999) FEBS
Lett. 452, 247^253.
[25] Suzuki, H., Chiba, T., Kobayashi, M., Takeuchi, M., Suzuki, T.,
Ichiyama, A., Ikenoue, T., Omata, M., Furuichi, K. and Tanaka,
K. (1999) Biochem. Biophys. Res. Commun. 256, 127^132.
[26] Kroll, M., Margottin, F., Kohl, A., Renard, P., Durand, H.,
Concordet, J.-P., Bachelerie, F., Arenzana-Seisdodes, F. and Be-
narous, R. (1999) J. Biol. Chem. 274, 7941^7945.
FEBS 22652 22-9-99
G.P. Ilyin et al./FEBS Letters 459 (1999) 75^79 79
